Manfred Zoltobrocki

Corporate Officer/Principal chez Lux Biosciences, Inc.

Health Technology

Consumer Services

Commercial Services

Postes actifs de Manfred Zoltobrocki

Sociétés	Poste	Début	Fin
Lux Biosciences, Inc. Lux Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Lux Biosciences, Inc. provides therapies for treatment of ophthalmic diseases. It develops and commercializes medications for ophthalmic diseases. The company was founded by Ulrich M. Grau, Eddy Anglade, Clarke A. Atwell and Sidney L. Weiss in 2006 and is headquartered in Jersey City, NJ.	Corporate Officer/Principal	21/10/2009	-

Sociétés	Poste	Début	Fin
NascaCell Technologies AG NascaCell Technologies AG Pharmaceuticals: MajorHealth Technology Nascacell Technologies Ag. offers improved, broadened and accelerated modern drug discovery. The company provides services like new generation of biomolecules with its Aptamer and Microbody technologies. Support is given to the customers in the areas of drug discovery and target validation. The company was founded in 2003 and is headquartered in Munich, Germany.	Directeur/Membre du Conseil	10/06/2010	08/02/2011
Epidauros Biotechnologie AG Epidauros Biotechnologie AG Miscellaneous Commercial ServicesCommercial Services Part of AbbVie, Inc., Epidauros Biotechnologie AG is a German company that specializes in pharmacogenomics research. The company is based in Bernried, Germany. Epidauros Biotechnologie was acquired by Clinical Data BV from Deutsche Effecten & Wechsel Beteiligungs AG on August 23, 2007 for $11.83 million.	President	-	01/03/2006
Aventis Pharma AG	Corporate Officer/Principal	01/01/2002	01/01/2002
Hoechst Marion Roussel SA	Corporate Officer/Principal	-	-
Hoechst Pharmaceuticals Ltd.	Corporate Officer/Principal	-	-

Johann Wolfgang Goethe-Universität Frankfurt am Main

Doctorate Degree

Internationale

Opérationnelle

Corporate Officer/Principal	4
President	1
Doctorate Degree	1

Sectorielle

Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Entreprise privées	6
Hoechst Marion Roussel SA	Health Technology
Lux Biosciences, Inc. Lux Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Lux Biosciences, Inc. provides therapies for treatment of ophthalmic diseases. It develops and commercializes medications for ophthalmic diseases. The company was founded by Ulrich M. Grau, Eddy Anglade, Clarke A. Atwell and Sidney L. Weiss in 2006 and is headquartered in Jersey City, NJ.	Health Technology
NascaCell Technologies AG NascaCell Technologies AG Pharmaceuticals: MajorHealth Technology Nascacell Technologies Ag. offers improved, broadened and accelerated modern drug discovery. The company provides services like new generation of biomolecules with its Aptamer and Microbody technologies. Support is given to the customers in the areas of drug discovery and target validation. The company was founded in 2003 and is headquartered in Munich, Germany.	Health Technology
Aventis Pharma AG
Epidauros Biotechnologie AG Epidauros Biotechnologie AG Miscellaneous Commercial ServicesCommercial Services Part of AbbVie, Inc., Epidauros Biotechnologie AG is a German company that specializes in pharmacogenomics research. The company is based in Bernried, Germany. Epidauros Biotechnologie was acquired by Clinical Data BV from Deutsche Effecten & Wechsel Beteiligungs AG on August 23, 2007 for $11.83 million.	Commercial Services
Hoechst Pharmaceuticals Ltd.